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Abstract
Background: Estrogen is a chemical messenger that has an inﬂuence on many breast cancers as it helps cells to
grow and divide. These cancers are often known as estrogen responsive cancers in which estrogen receptor occupies
the surface of the cells. The successful treatment of breast cancers requires understanding gene expression,
identifying of tumor markers, acquiring knowledge of cellular pathways, etc. In this paper we introduce our proposed
triclustering algorithm δ-TRIMAX that aims to ﬁnd genes that are coexpressed over subset of samples across a subset
of time points. Here we introduce a novel mean-squared residue for such 3D dataset. Our proposed algorithm yields
triclusters that have a mean-squared residue score below a threshold δ.
Results: We have applied our algorithm on one simulated dataset and one real-life dataset. The real-life dataset is a
time-series dataset in estrogen induced breast cancer cell line. To establish the biological signiﬁcance of genes
belonging to resultant triclusters we have performed gene ontology, KEGG pathway and transcription factor binding
site enrichment analysis. Additionally, we represent each resultant tricluster by computing its eigengene and verify
whether its eigengene is also diﬀerentially expressed at early, middle and late estrogen responsive stages. We also
identiﬁed hub-genes for each resultant triclusters and veriﬁed whether the hub-genes are found to be associated with
breast cancer. Through our analysis CCL2, CD47, NFIB, BRD4, HPGD, CSNK1E, NPC1L1, PTEN, PTPN2 and ADAM9 are
identiﬁed as hub-genes which are already known to be associated with breast cancer. The other genes that have also
been identiﬁed as hub-genes might be associated with breast cancer or estrogen responsive elements. The TFBS
enrichment analysis also reveals that transcription factor POU2F1 binds to the promoter region of ESR1 that encodes
estrogen receptor α. Transcription factor E2F1 binds to the promoter regions of coexpressed genesMCM7, ANAPC1
andWEE1.
Conclusions: Thus our integrative approach provides insights into breast cancer prognosis.
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Background
In the context of genomics research, the functional
approach is based on the ability to analyze genome-
wide patterns of gene expression and the mechanisms by
which gene expression is coordinated. Microarray tech-
nology and other high-throughput methods are used to
measure expression values of thousands of genes over dif-
ferent samples/experimental conditions. In recent years
the microarray technology has been used to measure in
a single experiment expression values of thousands of
genes under a huge variety of experimental conditions
across diﬀerent time points. This kind of datasets can be
referred to as time series microarray datasets. Because of
the large data volume, computational methods are used to
analyze such datasets. Clustering is one of the most com-
mon methods for identifying coexpressed genes [1]. This
kind of analysis is facilitative for constructing gene regula-
tory networks in which single or groups of genes interact
with other genes. Besides this, coexpression analysis also
reveals information about some unknown genes that form
a cluster with some known genes.
A clustering algorithm is used to group genes that
are coexpressed over all conditions/samples or to group
experimental conditions over all genes based on some
similarity/dissimilarity metric. However clustering may
fail to ﬁnd the group of genes that are similarly expressed
over a subset of samples/experimental conditions i.e. clus-
tering algorithms are unable to ﬁnd such local patterns
in the gene expression dataset. To deal with that prob-
lem, biclustering algorithms are used. A bicluster can
be deﬁned as a subset of genes that are coexpressed
over a subset of samples/experimental conditions. The
ﬁrst biclustering algorithm that was used to analyse gene
expression datasets was proposed by Cheng and Church
and they used a greedy search heuristic approach to
retrieve largest possible bicluster having mean squared
residue (MSR) under a predeﬁned threshold value δ
(δ-bicluster) [2]. But nowadays, biologists are eager to
analyze 3D microarray dataset to answer the question:
“Which genes are coexpressed under which subset of exper-
imental conditions/samples across which subset of time
points?” Biclustering is not able to deal with such 3D
datasets. So, in this case we need some other cluster-
ing technique that can mine 3D datasets. Hence the term
Triclustering has been deﬁned and a tricluster can be
delineated as a subset of genes that are similarly expressed
across a subset of experimental conditions/samples over
a subset of time points. Zhao and Zaki proposed a tri-
clustering algorithmTRICLUSTER that is based on graph-
based approach. They deﬁned coherence of a tricluster as
max(eib/eia,ejb/eja)
min(eib/eia ,ejb/eja) − 1, where eia, eib denote the expression
values of two columns a and b respectively for a row i. A
tricluster is valid if it has a ratio below a maximum ratio
threshold  [3].
Here we introduce an eﬃcient triclustering algorithm
δ-TRIMAX [4] that aims to cope with noisy 3D gene
expression dataset and is less sensitive to input param-
eters. The normalization method does not inﬂuence
the performance of our algorithm, as it produces the
same results for both normalized and raw datasets.
Here we propose a novel extension of MSR [2] for 3D
gene expression data and use a greedy search heuristic
approach to retrieve triclusters, having MSR values below
a threshold δ. Hence the triclusters can be deﬁned as
δ-tricluster.
In this work we have applied our proposed δ-TRIMAX
algorithm on a time-series gene expression data in estro-
gen induced breast cancer cell. Estrogen, a chemical
messenger plays an instrumental role in normal sex-
ual development, regulating woman’s menstrual cycles
and normal development of the breast. Estrogen is also
needed for heart and healthy bones. As estrogen plays
vital role in stimulating breast cell division, has an eﬀect
on other hormones implicated in breast cell division and
provides support to the growth of estrogen-responsive
tumors, it may be involved in risk for breast cancer
[5]. Though since last decade, some research has been
done to decipher some unknown questions on breast
cancer risk, still some questions such as involvement
of genes in breast cancer risk etc. remain unanswered.
Here our coexpression analysis reveals some genes that
have already been found to be associated with estrogen
induced breast cancer and some other genes that might
play an important role in this context. Additionally, our
coregulation analysis brings out some important infor-
mation such as which transcription factor binds the pro-
moter regions of genes and play an important role in this
context.
In section 2, we have described our proposed triclus-
tering algorithm in detail. Section 3 shows results of our
algorithm using one artiﬁcial dataset and one real-life
dataset. In section 4, we conclude our work.
Methods
Deﬁnitions
Deﬁnition 1 (Time Series Microarray Gene Expression
Dataset). We can model a time series microarray gene
expression dataset (D) as a G × C × T matrix and each
element of D (dijk) corresponds to the expression value of
gene i over jth sample/experimental condition across time
point k, where i ∈ (g1,g2,...,gG), j ∈ (c1,c2,...,cC) and k ∈
(t1,t2,...,tT ).
Deﬁnition 2 (Tricluster). A tricluster is deﬁned as a sub-
matrix M(I,J,K) = [mijk], where i ∈ I, j ∈ J and k ∈ K. The
submatrix M represents a subset of genes (I) that are coex-
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pressed over a subset of conditions (J) across a subset of
time points (K).
Deﬁnition 3 (Perfect Shifting Tricluster). A Tricluster
M(I,J,K) = mijk , where i ∈ I, j ∈ J and k ∈ K, is called
a perfect shifting tricluster if each element of the subma-
trix M is represented as: mijk =  + αi + βj + ηk, where
 is a constant value for the tricluster, αi, βj and ηk are
shifting factors of ith gene, jth samples/experimental con-
dition and kth time point, respectively. As the noise is
present in microarray datasets, the deviation from actual
value and expected value of each element in the dataset
also exists. For this deviation, every tricluster is not a
perfect one.
Cheng and Church proposed an algorithm for retriev-
ing large and maximal biclusters that have mean squared
residue score (MSR) below a threshold δ in 2D microar-
ray gene expression dataset. They also showed that MSR
of a perfect δ-bicluster and perfect shifting bicluster is
zero (S = δ = 0) [2,6]. Now extending this idea, here we
present a novel deﬁnition of Mean Squared Residue score
for 3D microarray gene expression datasets. The MSR (S)
of a perfect shifting tricluster becomes also zero, where
each element mijk =  + αi + βj + ηk . For delineating
new MSR score (S), at ﬁrst we need to deﬁne the residue
score:
Let the mean of ith gene (miJK ): miJK = 1|J||K |
∑
j∈J ,k∈K
mijk , the mean of jth sample/experimental condition
(mIjK ): mIjK = 1|I||K |
∑
i∈I,k∈K mijk , the mean of kth time
point (mIJk): mIJk = 1|I||J|
∑
i∈I,j∈J mijk , and the mean of
tricluster (mIJK ): mIJK = 1|I||J||K |
∑
i∈I,j∈J ,k∈K mijk . Now
the mean of the tricluster can be considered as the value
of constant i.e.  = mIJK . We can deﬁne the shifting
factor for the ith gene (αi) as the diﬀerence between
miJK and mIJK i.e. αi = miJK − mIJK . Similarly, we
can deﬁne shifting factor for the jth condition (βj) as
βj = mIjK − mIJK and shifting factor for the kth time
point (ηk) can be deﬁned as ηk = mIJk − mIJK . Hence
we can deﬁne each element of a perfect shifting triclus-
ter as mijk =  + αi + βj + ηk = mIJK + (miJK −
mIJK ) + (mIjK − mIJK ) + (mIJk − mIJK ) = (miJK + mIjK +
mIJk − 2mIJK ). But usually noise is evident in microarray
gene expression dataset. Therefore to evaluate the diﬀer-
ence between the actual value of an element (mijk) and its
expected value, obtained from above equation, the term
“residue” can be used [6]. Thus the residue of a triclus-
ter (rijk) can be deﬁned as follows: rijk = mijk − (miJK +
mIjK + mIJk − 2mIJK ) = (mijk − miJK − mIjK − mIJk+
2mIJK ).
Deﬁnition 4 (Mean Squared Residue). We deﬁne the term
Mean Squared Residue MSR(I,J,K) or S of a tricluster
M(I,J,K) to estimate the quality of a tricluster i.e. the level
of coherence among the elements of a tricluster as follows:








mijk − miJK − mIjK − mIJk + 2mIJK
)2.
Lower residue score represents larger coherence and
better quality of a tricluster.
Proposedmethod
δ-TRIMAX aims to ﬁnd largest and maximal triclusters in
a 3Dmicroarray gene expression dataset. It is an extension
of Cheng and Church biclustering algorithm [2] that deals
with 2-D microarray datasets. In contrast, our algorithm
is capable to mine 3D gene expression dataset. There is
always a submatrix in an expression dataset that has a per-
fect MSR(I,J,K) or S score i.e. S = 0 and this submatrix
is each element of the dataset. But as mentioned above,
our algorithm ﬁnds maximal triclusters having S score
under a threshold δ, hence we have used a greedy heuris-
tic approach to ﬁnd triclusters. Our algorithm therefore
starts with the entire dataset containing all genes, all
samples/experimental conditions and all time points.
Algorithm 1 (δ-TRIMAX):
Input. D, a matrix that represents 3D microarray gene
expression dataset, λ > 1, an input parameter for multi-
ple node deletion algorithm, δ ≥ 0, maximum allowable
MSR score.
Output. All possible δ-triclusters.
Initialization.Missing elements in D ← random num-
bers, D’ ← D
Repeat
a. D’1 ← Results of Algorithm 2 on D’ using delta and
λ. If the no. of genes (conditions/samples and/or no. of
time points) is 50 (This value can be choosen exper-
imentally. Large value increases the execution time of
the algorithm as it then executes more number of
iterations.), then do not apply Algorithm 2 on genes
(conditions/samples and/or time points).
b. D’2 ← Results of Algorithm 3 on D’1 using δ.
c. D’3 ← Results of Algorithm 4 on D’2.
d. Return D’3 and replace the elements that exist in D’
and D’3 with random numbers.
Until(No gene is found for δ-tricluster)
Initially, our algorithm removes genes or conditions or
time points from the dataset to accomplish largest dimin-
ishing of score S; this step is described in the following
section in which a node corresponds to a gene or experi-
mental condition or time point in the 3D microarray gene
expression dataset.
Algorithm 2 (Multiple node deletion):
Input. D, a matrix of real numbers that represents 3D
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microarray gene expression dataset; δ ≥ 0, maximum
allowable MSR threshold, λ > 1, threshold for multiple
node deletion. The value of λ has been set experimen-
tally to optimize the speed and performance (to avoid
falling into local optimum) of the algorithm.
Output.MIJK , a δ-tricluster, consisting of a subset(I) of
genes, a subset(J) of samples/experimental conditions
and a subset of time points, having MSR score (S) less
than or equal to δ.
Initialization. I ← {set of all genes}, J ← {set of all
experimental conditions/ samples} and K ← {set of all
time points} and to M(I,J,K) ← D
Repeat
Calculate miJK , ∀ i ∈ I; mIjK , ∀ j ∈ J; mIJk , ∀ k ∈ K; mIJK
and S.
If S ≤ δ return M(I,J,K)
Else
Delete genes i ∈ I that satisfy the following inequality
1
|J||K |	j∈J ,k∈K (mijk−miJK−mIjK−mIJk+2mIJK )
2>λS
Recalculate miJK , ∀ i ∈ I; mIjK , ∀ j ∈ J; mIJk , ∀ k ∈ K; mIJK
and S
Delete samples/experimental conditions j ∈ J that sat-
isfy the following inequality
1
|I||K |	i∈I,k∈K (mijk−miJK−mIjK−mIJk+2mIJK )
2>λS
Recalculate miJK , ∀ i ∈ I; mIjK , ∀ j ∈ J; mIJk , ∀ k ∈ K; mIJK
and S






Until(There is no change in I, J and/or K)
The complexity of this algorithm is O(max(m,n,p))
where m, n and p are the number of genes, samples and
time points in the 3D microarray dataset.
In the second step, we delete one node at each iteration
from the resultant submatrix, produced by Algorithm 2,
until the score S of the resultant submatrix is less than or
equal to δ. This step results in a δ-tricluster.
Algorithm 3 (Single node deletion):
Input. D, a matrix of real numbers that represents 3D
microarray gene expression dataset; δ ≥ 0, maximum
allowable MSR threshold.
Output.MIJK , a δ-tricluster, consisting of a subset(I) of
genes, a subset(J) of samples/experimental conditions
and a subset of time points, having MSR score (S) less
than or equal to δ.
Initialization. I ← {set of all genes in D}, J ← {set of
experimental conditions/samples in D} and K← {set of
time points in D} and to M(I,J,K) ← D
Calculate miJK , ∀ i ∈ I; mIjK , ∀ j ∈ J; mIJk , ∀ k ∈ K; mIJK
and S.
While S > δ
Detect gene i ∈ I that has the highest score
μ(i) = 1|J||K |	j∈J ,k∈K (mijk−miJK−mIjK−mIJk+2mIJK )
2
Detect sample/experimental condition j ∈ J that has the
highest score
μ(j) = 1|I||K |	i∈I,k∈K (mijk−miJK−mIjK−mIJk+2mIJK )
2
Detect time point k ∈ K that has the highest score
μ(k) = 1|I||J|	i∈I,j∈J (mijk−miJK−mIjK−mIJk+2mIJK )
2
Delete gene or sample/experimental condition or time
point that has highest μ score and modify I or J or K.




The complexity of ﬁrst and second steps is O(mnp) as
those will iterate (m+n+p) times. The complexity of selec-
tion of best genes, samples and time points is O(log m +
log n + log p). So it is suggested to use algorithm II before
algorithm 3.
As the goal of our algorithm is to ﬁnd maximal
triclusters, having MSR score (S) below the thresh-
old δ, the resultant tricluster M(I,J,K) may not be the
largest one. That means some genes and/or experimental
conditions/samples and/or time points may be added to
the resultant tricluster T produced by node deletion algo-
rithm, so that theMSR score of new tricluster T’ produced
after node addition does not exceed the MSR score of T.
Now the third step of our algorithm is described below.
Algorithm 4 (Node addition):
Input. D, a matrix of real numbers that represents
δ-tricluster, having a subset of genes (I), a subset of
experimental conditions/samples (J) and a subset of
time points (K).
Output. MI′J ′K ′ , a δ-tricluster, consisting of a subset of
genes (I’) , a subset of samples/experimental conditions
(J’) and a subset of time points (K’), such that I ⊂ I′ , J ⊂
J′ , K ⊂ K’ and MSR(I′ ,J′ ,K’) ≤ MSR of D.
Initialization.M(I,J,K) ← D
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Repeat
Calculate miJK , ∀ i; mIjK , ∀ j; mIJk , ∀ k; mIJK and S.
Add genes i 	∈ I that satisfy the following inequality
1
|J||K |	j∈J ,k∈K (mijk−miJK−mIjK−mIJk+2mIJK )
2 ≤ S
Recalculate mIjK , ∀ j; mIJk , ∀; mIJK and S
Add samples/experimental conditions j 	∈ J that satisfy
the following inequality
1
|I||K |	i∈I,k∈K (mijk−miJK−mIjK−mIJk+2mIJK )
2 ≤ S
Recalculate miJK , ∀ i; mIJk , ∀ k; mIJK and S





Until(There is no change in I, J and/or K)
I’ ← I, J’← J, K’ ← K
Return I’, J’, K’
The complexity of this algorithm is O(mnp) as each step
iterates (m+n+p) times.
Tricluster eigengene
To ﬁnd tricluster eigengene we applied singular value
decomposition method (SVD) on the expression data of
each tricluster [7]. For instance, Xig×(c∗t) represents the
expression matrix of ith tricluster, where g, c and t rep-
resent the number of genes, samples and time points of
ith tricluster. Now we apply SVD on the data matrix (nor-
malized to mean=0 and variance=1). Now, the SVD of ith
tricluster can be represented as,
Xi = UDVT , (2)
where U and V are the orthogonal matrices. Ui is a g ∗
(c ∗ t) matrix with orthonormal columns, Vi is a (c ∗ t) ×
(c ∗ t) orthogonal matrix andDi is (c ∗ t)× (c ∗ t) diagonal
matrix of singular values.
Assuming that singular values in matrix Di are arranged
in non-decreasing order, we can represent eigengene of ith
tricluster by the ﬁrst column of matrix Vi, i.e.
Ei = Vi1, (3)
Results and discussion
Results on simulated dataset
We have produced one simulated dataset SMD of size
2000 × 30 × 30. At ﬁrst we have implanted three per-
fect shifting triclusters of size 100 × 6 × 6, 80 × 6 ×
6 and 60× 5× 5 into the dataset SMD and then implanted
three noisy shifting triclusters of the same size mentioned
before into it. To estimate the degree of similarity between
the implanted and obtained triclusters, we deﬁne aﬃr-
mation score in the same way as Prelic et. al. deﬁned
for two sets of biclusters [6,8]. So, overall average aﬃr-
mation score of T1 with respect to T2 is as follows,
where (SM∗G(T1, T2)) is the average gene aﬃrmation score,
(SM∗C(T1, T2)) is the average sample aﬃrmation score and
(SM∗K (T1, T2)) is the average time point aﬃrmation score




(SM∗G(T1,T2)×SM∗C(T1,T2) × SM∗T (T1,T2))
(4)
Suppose, we have two sets of triclusters Tim and Tres
where Tim represents the set of implanted triclusters and
Tres corresponds to the set of triclusters retrieved by
any triclustering algorithm. Hence SM∗(Tim,Tres) denotes
how well the triclustering algorithm ﬁnds the true triclus-
ters that have been implanted into the dataset. This score
varies from 0 to 1 (if Tim = Tres).
For the dataset containing perfect shiﬁng triclusters, we
have assigned 0.35 and 1.0005 to the parameters δ and
λ, respectively. The value of δ varies from one dataset
to another dataset. Then we have added noisy triclusters
having diﬀerent levels i.e. standard deviations (σ = 0.1, 0.3,
0.5, 0.7, 0.9, 1.1, 1.3, 1.5, 1.7). To have an idea about the δ
value, we have ﬁrst clustered the genes over all time points
and then the time points over the subset of genes for
each gene cluster in each sample plane using the K-means
algorithm. Then we have computed the MSR value(S) of
the submatrix, considering a randomly selected sample
plane, gene and time-pont cluster for 100 times. Then we
have taken the lowest value as the value of δ. For these
noisy datasets, we have assigned 3.75 and 1.004 to the
parameters δ and λ, respectively. In Figure 1 we have com-
pared the performance of our algorithm with that of the
TRICLUSTER algorithm [3] in terms of aﬃrmation score
using the artiﬁcial dataset. Our δ-TRIMAX algorithm per-
forms better than TRICLUSTER algorithm for the noisy
dataset. For perfect additive triclusters, performances of
both these algorithms are comparable with each other.
Results on real-life dataset
Datasets for genome-wide analysis of estrogen recep-
tor binding sites This dataset contains 54675 aﬀymetrix
probe-set ids, 3 biological replicates and 4 time points.
In this experiment MCF7 cells are stimulated with 100
nm estrogen for 0, 3, 6 and 12 hours and the experi-
ments are performed in triplicate. This dataset is publicly
available at Gene Expression Omnibus (GEO) (dataset id-
GSE 11324). It was used for discovering of cis-regulatory
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Figure 1 Comparison in terms of Aﬃrmation Scores. a. Comparison of Aﬃrmation scores produced by -TRIMAX and TRICLUSTER algorithm.
b. Comparison of running time of -TRIMAX and TRICLUSTER algorithm on the synthetic dataset.
sites in previously uninvestigated regions and cooperat-
ing transcription factors underlying estrogen signaling in
breast cancer [9]. We assign 0.012382 and 1.2 to δ and
λ respectively. In this case our algorithm results in 115
triclusters. From Figure 2, we observe that the genes in
tricluster 4 have similar expression proﬁles over all three
samples across 0, 6 and 12 hours but not at 3 hour.
To compare the performance of our proposed algorithm
with TRICLUSER algorithm on real-life dataset, we have
used three validation indexes.
Coverage
Coverage for any triclustering algorithm can be delineated
as
Coverage =
(galg × calg × talg
G × C × T
)
× 100, (5)
where galg , calg and talg denote total number of genes,
experimental samples and time points retrieved by the
triclustering algorithm. G, C and T represent number of
Figure 2 Expression Proﬁles. Figures in ﬁrst row show the expression proﬁles of genes ESR1, HOXA11, FAM71A, SPEF2, IFIH1, FPR2, SPAG9, NCF4,
ADAM3A, CCNYL1 respectively of tricluster 4 over all samples; The red-colored time point (3 hrs.) is not a member of this tricluster. The ﬁgures in
second row show the expression proﬁles of the same genes across 0, 6 and 12 hours.
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all genes, experimental samples and time points in the
dataset.
Triclustering Quality Index (TQI)
We can elucidate Triclusering Quality Index of a tricluster
by equation 4.
TQI = MSRiVolumei , (6)
whereMSRi andVolumei represent mean-squared residue
and volume of ith tricluster. Lower TQI score represents
better quality of tricluster.
Statistical Diﬀerence from Background (SDB)
Here we have introduced another quality measurement,









j=1 RMSRj − MSRi
, (7)
where n is the total number of triclusters extracted by
the algorithm. MSRi represents mean squared residue of
ith tricluster retrieved by the algorithm and RMSRj rep-
resents mean squared residue of jth random tricluster
having the same number of genes, experimental samples
and time points as that of ith resultant tricluster. Here
higher value of the denominator denotes better quality of
the resultant tricluster. Hence, lower SDB score signiﬁes
better performance of the algorithm. Table 1 shows the
comparison between proposed δ-TRIMAX algorithm and
TRICLUSTER algorithm in terms of coverage, SDB and
TQI score.
Biological signiﬁcance
We have established the biological signiﬁcance of genes
belonging to each resultant tricluster by performing
(a) Gene Ontology (GO) and KEGG pathway enrich-
ment analysis, (b) cogitating each tricluster with diﬀerent
estrogen-responsive stages (early (3 hour), middle (6 hour)
and late (12 hour)), (c) identifying hub genes of each tri-
cluster and (d) Transcription Factor Binding Site (TFBS)
enrichment analysis.
Table 1 Comparison between δ-TRIMAX and TRICLUSTER
algorithm using coverage, Statistical Diﬀerence of from
Background (SDB) and Triclustering Quality Index (TQI)
Algorithm Coverage SDB Average TQI
δ-TRIMAX 93.7412 0.4670856 3.082684e-05
TRICLUSTER 72.34019 0.4775341 3.348486e-05
GO and KEGG pathway enrichment analysis
We have used GOStats package [11] in R to perform
GO and KEGG pathway enrichment analysis for estab-
lishing biological signiﬁcance of genes belonging to each
tricluster. We have adjusted the p-values using Benjamini-
Hochberg FDR method [12] and considered those terms
as signiﬁcant ones that have a p-value below a threshold
of 0.05. The smaller p-value represents higher signiﬁcance
level. We have found statistically enriched GO terms for
genes belonging to each tricluster. We have compared the
performance of our proposed δ-TRIMAX algorithm with
that of TRICLUSTER algorithm on real-life dataset. For
comparison of the performances we have considered GO
Biological Processes (GOBP) and KEGG pathway terms
that have already been reported to play an important role
in estrogen induced breast cancer cell. Table 2 shows the
comparison between δ-TRIMAX and TRICLUSTER algo-
rithm in terms corrected p-values of GOBP and KEGG
pathway terms cell adhesion and Wnt signaling pathway
that are observed to be associated with estrogen induced
breast cancer [13,14], respectively.
Association of triclusters with diﬀerent stages of response to
estrogen stimulus
To cogitate each tricluster with diﬀerent estrogen respon-
sive stages of the experiment, we represent each triclus-
ter by eigengene. Then we have examined whether the
eigengene of each tricluster is diﬀerentially expressed at
early, middle and late estrogen responsive stages using
Limma package in R [15] (FDR-BH corrected p-value cut-
oﬀ 0.05). If eigengene of one tricluster is found to be
diﬀerentially expressed at any possible responsive stages,
then the genes having highly correlated expression pro-
ﬁles with that of eigengene can also be considered to
be signiﬁcantly expressed at the same stages. In total
our algorithm results in 115 triclusters. Eigengene of tri-
cluster 7 has been found to be diﬀerentially expressed
between 0 hour - 6 hours, 0 hour - 12 hours, 3 hours -
12 hours and 6 hours - 12 hours. 429 genes among 505
genes are found to be diﬀerentially expressed in this tri-
cluster. KEGG pathway term mTOR signaling pathway is
observed to be meliorated in this tricluster and has been
reported to be associated with estrogen induced breast
cancer cell [16]. Genes PIK3CA, PRKAA1, RPS6, ULK2
Table 2 Comparison between δ-TRIMAX and TRICLUSTER
algorithm in terms of p-values of GO and KEGG pathway
term enrichment analysis
Algorithm GOBP term KEGG pathway terms
δ-TRIMAX GO:0007155: cell adhesion KEGG:04310: Wnt signaling
(4.31e-08) pathway (0.011)
TRICLUSTER GO:0007155: cell adhesion KEGG:04310: Wnt signaling
(0.00022) pathway (0.03)
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participate in that pathway. The genes belonging to tri-
cluster 50 are coexpressed over all samples across 0, 6
and 12 hours. The eigengene of tricluster 50 has been
observed to be diﬀerentially expressed between 0 hour -
12 hours and 6 hours - 12 hours. 96% of the genes
belonging to this tricluster are found to be diﬀerentially
expressed. The genes in this tricluster are meliorated with
the KEGG pathway term ubiquitin mediated proteolysis
(UBE2K, CUL4B, PIAS1, CDC23). It has been reported
in a previous study that there is crosstalk between ERα
and targets of ERα for ubiquitin mediated proteolysis
[17]. In tricluster 71 time points 3, 6 and 12 hours are
present in that tricluster and the eigengene is signiﬁcantly
expressed between 3 hours and 12 hours. 44 genes out
of 52 genes in this tricluster are signiﬁcantly expressed
between 3 and 12 hours. Genes belonging to this tricluster
are also enriched with the KEGG pathway term ubiqui-
tin mediated proteolysis (UBA6, BIRC6, ANAPC1, CUL5).
Genes belonging to tricluster 48 are coexpressed across
0, 3 and 12 hours. Eigengene of tricluster 48 is signiﬁ-
cantly expressed between 0 and 12 hours, 3 and 12 hours.
The KEGG pathway term TGF-beta signaling pathway is
meliorated in this tricluster and the crosstalk between
TGF-beta signaling pathway and ERα has been reported
in a previous study [18]. Genes SKP1, BMPR2 are found
to play a role in the enriched pathway. Eigengene of tri-
cluster 95 is signiﬁcantly upregulated between 0 and 12
hours. 60% of all genes belonging to this tricluster are dif-
ferentially up regulated at late responsive stage. The genes
in this tricluster has been found to be coexpressed across
0 hour, 12 hours over all samples. The KEGG pathway
term apoptosis (XIAP, IRAK4, CASP6) is observed to be
meliorated in this tricluster and it has been found in a
recent study that apoptosis can be induced by estrogen in
estrogen deprivation-resistant breast cancer cell [19]. The
genes of that tricluster 75 have been observed to be coex-
pressed over all samples across 3 and 12 hours. The eigen-
gene of tricluster 75 is diﬀerentially expressed between 3
hours and 12 hours. 39 genes among 64 genes are sig-
niﬁcantly expressed between 3 and 12 hours. In this case
we have observed enrichment for KEGG pathway terms
ErbB signaling pathway that is found to be associated with
estrogen induced breast cancer cell [20]. The coexpressed
genes NCK1, SOS2 in this tricluster participate in that
pathway.
Identiﬁcation and roles of hub genes
To identify hub genes of each tricluster, we have com-
puted tricluster membership of each gene by calculating
Pearson correlation coeﬃcient between each gene and
the eigengene of that tricluster. We have considered the
top ﬁfteen genes as hub genes having highest correlation
coeﬃcient with the eigengene of that tricluster. For tri-
cluster 1, we have identiﬁed NPC1L1, TMEM161B-AS1,
POU5F1P3, POU5F1P4, POU5F1B, CCL2 as hub-genes
that are coexpressed over all-time points. It has been
observed in a previous study that high doses of estro-
gen augment intestinal cholesterol absorption attributable
in part to an up-regulated expression of NPC1L1 which
is known as intestinal sterol inﬂux transporter [21].
CCL2 is found to play an important role in mediat-
ing cross-talk between cancer cells and stromal ﬁbrob-
lasts in breast cancer cells [22]. DNAJC3-AS1, ITSN2,
TRPC1, CD47, ZNF286A, TSC22D2, PHF17, ZNF286B,
TMEM67, NFIB, JKAMP, DENND4A, HPGD are identi-
ﬁed as hub-genes that are coexpressed over all samples
and 0, 3, 6 and 12 hours in tricluster 7. NFIB has been
reported as a potential target of ER negative breast can-
cers [23]. Transient receptor potential cation channel
(TRPC1) is known to play an important role in breast
cancer [24]. CD47 has been found to intervene killing of
breast cancer cells [25]. HPGD plays important role in
epithelial-mesenchymal transition andmigration in breast
cancer cells [26]. In tricluster 4, the genes are coex-
pressed over 0, 6 and 12 hours and IGKV1-13, FAM69C,
SGCD, CSNK1E, TRMU, CRYBA2, IGKV1D-13, IGSF11,
PACS1, IQCK are identiﬁed as hub-genes. CSNK1E has
been observed to play an important role proliferation of
breast cancer cells and act as a regulator of activated -
catenin driven transcription [27]. For tricluster 13 we have
identiﬁed ESYT3, SERINC2, LRRC14, ALDH4A1, RPL10,
BRD4, DEC1, ZFP30, TCP11L2, ALDOA as hub-genes.
The gene for Aldolase A (ALDOA) plays an instrumental
role in hypoxia which is a feature of solid tumors in breast
cancer [28]. Besides this BRD4 known as Bromodomain
4 is found to be associated with breast cancer progres-
sion [29]. Genes PFKFB1, TAF1, PIKFYVE, MEMO1P1,
KIF1B, PHF20L1, ARHGAP24, TSC22D1, AK7, DPY30,
MEMO1, PTEN, ADAM9, PTPN2, MTSS1L are found as
hubgenes of tricluster 95. PTEN is known to be a tumor
suppressor gene in breast cancer [30,31]. PTPN2, ADAM9
have been reported to be associated with breast cancer
in previous studies [32,33]. PIKFYVE has been found to
intervene epidermal growth factor receptor that is asso-
ciated with human breast cancers [34]. In case of triclus-
ter 42, ANTXR2, RHBDL2, GSTCD, DENND1B, KLC3,
PREP, NOS1, STOML3, CDK5R1, CLEC7A, HGD, FOXC1,
MSRB3, TEX34, SLC36A1 are appeared as hub-genes that
are coexpressed over all samples and across 0, 12 hours.
In a recent work, the activity of RHBDL2 has been iden-
tiﬁed in many tumour cells including breast cancer [35].
The role of FOXC1 as a regulator of human breast cancer
cells by activating NFκB signaling has been discovered in
a recent work [36].
TFBS enrichment analysis
To analyse the potential coregulation of coexpressed
genes, we have done transcription factor binding site
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Table 3 TRANSFACMatrices for Triclusters, having statistically enriched TFBS for real-life dataset
Tricluster (no. of genes) 20 most signiﬁcant TRANSFAC matrices (in ascending order of
p-values)
FDR-BY corrected p-value of
top-most matrix
Tricluster 3 (875) V$NCX 02, V$MSX1 02, V$PAX4 02, V$POU3F2 01, V$TBP 01,
V$BRN3C 01, V$BARX2 01, V$HB24 02, V$HOXD10 01, V$BARX1 01,
V$DBX1 01, V$HMBOX1 01, V$HDX 01, V$BSX 01, V$NKX52 01,
V$HMX3 02, V$LBX2 01, V$HOXD13 01, V$NFAT1 Q6, V$HOXD8 01
4.29e-08
Tricluster 1 (4477) V$NCX 02, V$HDX 01, V$BCL6 01, V$ZNF333 01, V$DLX2 01,
V$DLX7 01, V$DLX5 01, V$SRY 02, V$BARX1 01, V$SOX4 01,
V$NKX24 01, V$HOXD3 01, V$LBX2 01, V$LHX61 02, V$SRY 01,
V$TST1 01, V$DLX3 01, V$XVENT1 01, V$EVX1 01, V$BARX2 01
1.27e-05
Tricluster 26 (3177) V$E2F Q2, V$ZF5 01,V$USF2 Q6, V$SP1 Q6 01, V$KID3 01, V$CHCH 01 2.99e-05
Tricluster 4 (3482) V$BCL6 01, V$HOXA10 01, V$SRY 01, V$NKX23 01, V$WT1 Q6,
V$HOXB9 01, V$ISL2 01, V$HOXD10 01, V$HOXD8 01, V$NCX 02,
V$X1 02, V$PAX4 04, V$BARHL2 01, V$DLX1 01, V$SRY 02, V$OCT1 03,
V$DLX5 01, V$LHX9 01, V$DBX2 01, V$HMGIY Q6
9.51e-05
Tricluster 2 (2186) V$CHCH 01, V$MOVOB 01, V$MAZ Q6, V$PAX4 03, V$CACD 01,
V$GEN INI3B B, V$GEN INI B, V$CKROX Q2
0.0001
Tricluster 12 (476) V$SRY 02, V$NCX 02, V$BCL6 01, V$HB24 01, V$HOXA10 01,
V$NKX25 02, V$SRY 01, V$PBX1 02, V$HOXD10 01
0.002
Tricluster 17 (999) V$CREB 01, V$CREBATF Q6, V$SP1 Q6 01, V$ATF3 Q6,
V$CREBP1CJUN 01
0.004
Tricluster 50 (182) V$ETF Q6 0.006
Tricluster 18 (260) V$STAT1STAT1 Q3 0.042
Tricluster 31 (2465) V$SP1 Q6 01 0.046
(TFBS) enrichment analysis using the TRANSFAC library
(version 2009.4) [37] that contains eukaryotic transcrip-
tion factors, their experimentally proven binding sites,
and regulated genes. Here we used 42,544,964 TFBS
predictions that have high aﬃnity scores and are con-
served between human, mouse, dog and cow [38]. Out
of these 42 million conserved TFBSs we have selected
the best 1% for each TRANSFAC matrix individually to
identify the most speciﬁc regulator (transcription fac-
tor) - target interactions. We have used hypergeomet-
ric test [39] and Benjamini Yekutieli-FDR method [40]
for p-value correction to ﬁnd over-represented binding
sites (p-value ≤ 0.05) in the upstream regions of genes
belonging to each tricluster. Table 3 shows the list of
triclusters where we have found statistically meliorated
TFBSs. From Table 3, we can observe that the genes
Table 4 Statistically enriched KEGG pathway terms for diﬀerentially expressed and coexpressed targets of TRANSFAC
matrices V$NFAT1 Q6, V$OCT1 03, V$CREB 01, V$CREBATF Q6, V$E2F Q2 and V$SP1 Q6 01
Tricluster TRANSFACmatrix KEGG pathway terms (corrected p-value≤ 0.05)
4 V$NFAT1 Q6 KEGG: 00471: D-Glutamine and D-glutamate metabolism (GLS),
KEGG: 04310: Wnt signaling pathway (PPP2R1B, ROCK1, TBL1X),
KEGG: 04350: TGF-beta signaling pathway (ROCK1, TBL1X),
4 V$OCT1 03 KEGG: 04961: Endocrine and other factor-regulated calcium reab-
sorption (SLC8A1, ESR1)
17 V$CREB 01 KEGG: 00030: Pentose phosphate pathway (RBKS), KEGG: 04012:
ErbB signaling pathway (PAK1), KEGG: 05211: Renal cell carcinoma
(PAK1)
17 V$CREBATF Q6 KEGG: 04660: T cell receptor signaling pathway (PAK1), KEGG: 04650:
Natural killer cell mediated cytotoxicity (PAK1, KEGG: 05120: Epithe-
lial cell signaling in Helicobacter pylori infection (PAK1), KEGG:
04360: Axon guidance (PAK1)
26 V$E2F Q2 KEGG: 04110: Cell cycle (MCM7, ANAPC1, WEE1), KEGG: 03030: DNA
replication (MCM7, POLA1)
26 V$SP1 Q6 01 KEGG: 00100: Steroid biosynthesis (SQLE), KEGG: 00270: Cysteine
and methionine metabolism (MAT2A), KEGG: 04962: Vasopressin-
regulated water reabsorption (CREB1), KEGG: 04623: Cytosolic DNA-
sensing pathway (MAVS)
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in tricluster 26 are enriched with helix-turn-helix, zinc-
coordinating DNA-binding and basic domain transcrip-
tion factors. The helix-turn-helix domain transcription
factor E2F1, to which TRANSFAC matrix V$E2F Q2
is associated acts as a regulator of cell proliferation in
estrogen-induced breast cancer cell [41]. The zinc ﬁn-
ger transcription factors Sp1 and Sp4, asociated with
matrix V$SP1 Q6 01 have already been reported to play
an important role in estrogen-induced MCF-7 breast can-
cer cell line [42,43]. In tricluster 17, the basic domain
transcrption factor CREB (matrix V$CREB 01) is impor-
tant for malignancy in breast cancer cell. ATF1, ATF2,
ATF3, ATF4, ATF5 (matrix V$CREBATF Q6) likewise
play an important role in breast cancer cell [44]. We have
observed enrichment for matrix V$NFAT1 Q6. The cor-
responding transcription factor (NFATC1) has been found
to be associated with clinical characteristics in breast
cancer cell [45]. In tricluster 4 POU2F1, the TF associ-
ated withmatrix V$OCT1 03 is a helix-turn-helix domain
transcription factor (Oct-1) and has been reported
to be estrogen-responsive in a previous study [46].
Table 4 shows some statistically enriched KEGG path-
way terms for coexpressed and diﬀerentially expressed
(using adjusted p-value ≤ 0.05) genes the promoters
of which are bound by aforementioned transcription
factors.
Conclusion
In this work we have proposed δ-TRIMAX triclustering
algorithm that aims to retrieve large and coherent groups
of genes, having an MSR score below a threshold δ. Genes
belonging to each tricluster are coexpressed over a sub-
set of samples/ experimental conditions and across subset
of time points. The results of GO and KEGG pathway
enrichment analysis show that our proposed algorithm is
able to extract group of coexpressed genes that are biolog-
ically signiﬁcant. We have performed TFBS enrichment
analysis to establish the fact that the promoter regions
of the genes having similar expression proﬁle are bound
by the same transcription factors. We have compared
the performance of our algorithm with that of existing
algorithm using one artiﬁcial dataset in terms of aﬃrma-
tion score and one real-life dataset in terms of coverage,
statistical diﬀerence from background and triclustering
quality index score. In case of these two datasets our pro-
posed algorithm outperformed the existing one. Addition-
ally, here we have represented the expression proﬁles of
genes belonging to each tricluster by eigengene and then
identiﬁed hub genes using the proﬁle of eigengene. We
have observed that most of the identiﬁed hub-genes are
previously reported to be associated with breast cancer
and estrogen responsive elements. The other identiﬁed
hub genes might be associated with breast cancer and
need to be veriﬁed experimentally. Hence our integrative
approach and ﬁndings might provide new insights into
breast cancer prognosis.
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